Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitul Shah

Showing results (51-60 of 142) with videos related to

Pageof 15
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 7, 2016
Genetic modifiers of CHEK2*1100delC-associated breast cancer riskTaru A Muranen, Dario Greco, Carl Blomqvist, et al.
Cancers|July 27, 2022
Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European AncestryMartine Dumont, Nana Weber-Lassalle, Charles Joly-Beauparlant, et al.
American Journal of Human Genetics|February 24, 2023
The impact of coding germline variants on contralateral breast cancer risk and survivalAnna Morra, Nasim Mavaddat, Taru A Muranen, et al.
Breast Cancer Research : BCR|January 4, 2011
Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control studyRoger L Milne, Mia M Gaudet, Amanda B Spurdle, et al.
The Journal of Pathology|December 13, 2021
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomasKarolin Heinze, Tayyebeh M Nazeran, Sandra Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2019
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastasesNicola S Meagher, Linyuan Wang, Peter F Rambau, et al.
Human Genetics|December 2, 2015
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association ConsortiumJieping Lei, Anja Rudolph, Kirsten B Moysich, et al.
Endocrine-Related Cancer|November 18, 2015
CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancerDeborah J Thompson, Tracy A O'Mara, Dylan M Glubb, et al.
Human Genetics|December 10, 2014
Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer riskLuis G Carvajal-Carmona, Tracy A O'Mara, Jodie N Painter, et al.
Nature Genetics|May 3, 2016
Five endometrial cancer risk loci identified through genome-wide association analysisTimothy Ht Cheng, Deborah J Thompson, Tracy A O'Mara, et al.
Pageof 15

Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 7, 2016
Genetic modifiers of CHEK2*1100delC-associated breast cancer riskTaru A Muranen, Dario Greco, Carl Blomqvist, et al.
Cancers|July 27, 2022
Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European AncestryMartine Dumont, Nana Weber-Lassalle, Charles Joly-Beauparlant, et al.
American Journal of Human Genetics|February 24, 2023
The impact of coding germline variants on contralateral breast cancer risk and survivalAnna Morra, Nasim Mavaddat, Taru A Muranen, et al.
Breast Cancer Research : BCR|January 4, 2011
Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control studyRoger L Milne, Mia M Gaudet, Amanda B Spurdle, et al.
The Journal of Pathology|December 13, 2021
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomasKarolin Heinze, Tayyebeh M Nazeran, Sandra Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2019
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastasesNicola S Meagher, Linyuan Wang, Peter F Rambau, et al.
Human Genetics|December 2, 2015
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association ConsortiumJieping Lei, Anja Rudolph, Kirsten B Moysich, et al.
Endocrine-Related Cancer|November 18, 2015
CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancerDeborah J Thompson, Tracy A O'Mara, Dylan M Glubb, et al.
Human Genetics|December 10, 2014
Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer riskLuis G Carvajal-Carmona, Tracy A O'Mara, Jodie N Painter, et al.
Nature Genetics|May 3, 2016
Five endometrial cancer risk loci identified through genome-wide association analysisTimothy Ht Cheng, Deborah J Thompson, Tracy A O'Mara, et al.
Pageof 15